WeVote
Log In

Bill

Bill

SD 676

An Act to reduce incidence and death from pancreatic cancer

194th Legislature (2025-2026) Introduced by Will Brownsberger and 17 co-sponsors

Massachusetts bill referred to Public Health committee to reduce pancreatic cancer incidence and mortality through unspecified legislative mechanisms.

House concurred
0
WeVote Research Nonpartisan
Bill Summary · SD 676

Legislative bill overview

SD 676 aims to reduce incidence and death from pancreatic cancer in Massachusetts through legislative action. The bill was recently referred to the Public Health committee after House concurrence. The specific mechanisms for achieving these reductions are not detailed in the available legislative summary data provided.

Why is this important

Pancreatic cancer has one of the lowest five-year survival rates among all cancers (approximately 11%), making it a significant public health priority. Targeted legislative measures could address prevention, early detection, treatment access, or research funding—areas where policy changes can measurably impact outcomes.

Potential points of contention

  • Implementation costs: Any new screening programs, research funding, or healthcare initiatives will require budget allocation and may face fiscal scrutiny
  • Screening efficacy debate: Pancreatic cancer screening remains medically complex; disagreement may exist over which populations should be screened and cost-benefit ratios
  • Scope of intervention: Stakeholders may disagree on whether the bill should focus on prevention, research funding, treatment access, patient support services, or a combination approach

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.